South African Medical News

Back to Home Page

Print using browser
Adcock Ingram - Stock Notification - Estalis 50/140 (oestradiol, norethisterone)

adcocklogo2







Dear Healthcare Professional

Adcock Ingram and Novartis regret to inform you that they are anticipating a decline in the availability of Estalis Transdermal Patches.

Unfortunately, this is due to a cessation in supply from the global manufacturer that is beyond their control. In the weeks to follow, Adcock Ingram and Novartis will begin to experience stock outages. Adcock Ingram and Novartis kindly request that you take this into consideration and manage your patients accordingly.

If you have any further queries regarding this matter, please contact the Novartis Customer Care Line on 0861 929 929 or the Adcock Ingram Medical Affairs department by email,         * This is a drug - read the leaflet carefully before use. 

        * Ask your doctor or pharmacist for further information. 

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

Adcock Ingram and Novartis apologise for any inconvenience caused and thank you for your continued support.

Adcock Ingram Limited. Reg. No. 1949/034385/06 Private Bag X69, Bryanston, 2021 Tel. + 27 11 635 0000.


You need to be logged in to see more details. Register Now!


Click here to visit the Adcock website.....
Contact: Anneke Vlok, Women's Health Brand Manager
Telephone: +27 (0) 11 635 0620
E-mail: Anneke.Vlok@adcock.com
Date: Tuesday, August 22, 2017